the sales dropped and manufacturing costs increased because they are revamping the adult dairy segment brands which makes up a large portion of the china sales. the bubs portfolio sales, more specifically the infant formula, are increasing nicely - they have the highest margin and are the most profitable products which is good to see. hopefully all the synergies within the supply chain will be realised over the next 12 months so manufacturing costs can lean up. same point as last year sales are up 75% - and with the increased inventories and expansion into new markets lets hope it is upwards from here
- Forums
- ASX - By Stock
- BUB
- Ann: FY20 Q2 Activities Report and Appendix 4C Cashflow Statement
Ann: FY20 Q2 Activities Report and Appendix 4C Cashflow Statement, page-49
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.0¢ |
Change
0.005(3.70%) |
Mkt cap ! $118.2M |
Open | High | Low | Value | Volume |
13.5¢ | 14.0¢ | 13.0¢ | $179.2K | 1.328M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 1958180 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 961442 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 1958180 | 0.130 |
51 | 3829215 | 0.125 |
67 | 3909216 | 0.120 |
28 | 1681963 | 0.115 |
34 | 813126 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 964313 | 28 |
0.145 | 521511 | 17 |
0.150 | 1005594 | 31 |
0.155 | 164334 | 10 |
0.160 | 190718 | 11 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BUB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online